WHM logo white WHM logo white

Online learning

E-learning modules - CPD-accredited modules to develop your knowledge and skills.

E-learning modules

Heavy Menstrual Bleeding (HMB): evidence-based learning for best practice
Heavy Menstrual Bleeding (HMB): evidence-based learning for best practice

A 30-minute, scientific e-learning course developed by the HELP expert panel of independent physicians*. Three case-based modules cover the diagnostic pathway and treatment algorithm for HMB to help you to counsel your patients effectively.

The Bayer intrauterine techniques training programme
The Bayer intrauterine techniques training programme

Practical training and support for GPs and nurses who wish to gain their letter of competence in intrauterine techniques (LoC IUT) and complete the faculty of sexual and reproductive healthcare (FSRH) diploma.

More information
Contraception and IUS counselling
Contraception and IUS counselling

Contraception and IUS counselling This eLearning module covers how to successfully counsel women around contraception focusing on Intrauterine contraception – the IUS.

  • The formation of the HELP expert panel and its ongoing work is supported by Bayer AG. Return to content
Addressing the myths of intrauterine contraception (IUC)
Addressing the myths of intrauterine contraception (IUC)

Patient misconceptions are a common reason why IUC are not more widely used, despite being recommended as a first-line treatment option for HMB†1,2. This web conference takes a look at the evidence that can help you to combat patient concerns and assess suitable long-term treatment options.

Case-based learning: individualising care to meet your patients’ needs
Case-based learning: individualising care to meet your patients’ needs

Three relatable case studies to help you determine the right diagnostic pathway and the most appropriate treatment options for the different patient types in your clinic.

  • For women with no identified pathology, fibroids less than 3 cm in diameter, which are not causing distortion of the uterine cavity, or suspected or diagnosed adenomyosis.2 Return to content

Recommendations

Therapy areas

Therapy areas
Fitter resources

Fitter resources

Related topics

On-demand training Recorded webinars Upcoming webinars

Reporting adverse events and quality complaints

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.

 

If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 01182063500 or email: pvuk@bayer.com

 

Further information is available on the “contact” tab at www.bayer.co.uk.

Copyright © 2021 Bayer plc

 

This website is intended for UK healthcare professionals only. Women’s Health Matters is organised and funded by Bayer and contains promotional content.

 

Prescribing Information (PI) can be found via the links below:
Mirena® (52 mg intrauterine delivery system Levonorgestrel)
Kyleena® (19.5 mg intrauterine delivery system Levonorgestrel)
Jaydess®▼ (13.5 mg intrauterine delivery system Levonorgestrel)
Qlaira® (estradiol valerate/dienogest)
Microgynon® (levonorgestrel/ethinylestradiol)

  • PP-PF-WHC-GB-0837 June 2021

Last updated on 10/06/21

Bayer logo